Aggravated behavioral and neurochemical deficits and redox imbalance in mice with enhanced neonatal iron intake: improvement by biochanin A and role of microglial p38 activation

References

• Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2014;29(9):541–9. doi: 10.1016/j.nrl.2012.04.001
   PubMed Web of Science ®Google Scholar
• Mori MA, Delattre AM, Carabelli B, Pudell C, Bortolanza M, Staziaki PV, et al. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase. Nutr Neurosci. 2018;21(5):341–51. doi: 10.1080/1028415X.2017.1290928
   PubMed Web of Science ®Google Scholar
• Mata I, Leverenz J, Weintraub D, Trojanowski J, Hurtig H, Van Deerlin V, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol. 2014;71(11):1405–12. doi: 10.1001/jamaneurol.2014.1455
   PubMed Web of Science ®Google Scholar
• Ostojic S. Inadequate production of H2 by gut microbiota and Parkinson disease. Trends Endocrinol Metab. 2018;29(5):286–8. doi: 10.1016/j.tem.2018.02.006
   PubMed Web of Science ®Google Scholar
• Akman M, Cebeci D, Okur V, Angin H, Abali O, Akman A. The effects of iron deficiency on infants’ developmental test performance. Acta Paediatr. 2004;93(10):1391–6. doi: 10.1111/j.1651-2227.2004.tb02941.x
   PubMed Web of Science ®Google Scholar
• Wang J, Wu W, Huang H, Li W, Chen H, Yin Y. Biochanin A protects against lipopolysaccharide-induced damage of dopaminergic neurons both In Vivo and In vitro via Inhibition of microglial activation. Neurotox Res. 2016;30(3):486–98. doi: 10.1007/s12640-016-9648-y
   PubMed Web of Science ®Google Scholar
• Alves G, Müller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, et al. Incidence of Parkinson's disease in Norway: the Norwegian Park West study. J Neurol Neurosurg Psychiatry. 2009;80(8):851–7. doi: 10.1136/jnnp.2008.168211
   PubMed Web of Science ®Google Scholar
• Barnham K, Masters C, Bush A. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3(3):205–14. doi: 10.1038/nrd1330
   PubMed Web of Science ®Google Scholar
• Junxia X, Hong J, Wenfang C, Ming Q. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp Neurol. 2003;182(2):483–9. doi: 10.1016/S0014-4886(03)00123-7
   PubMed Web of Science ®Google Scholar
• Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo J, Boonplueang R, et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron. 2003;37(6):899–909. doi: 10.1016/S0896-6273(03)00126-0
   PubMed Web of Science ®Google Scholar
• Nataraj J, Manivasagam T, Thenmozhi AJ, Essa MM. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nutr Neurosci. 2016;19(6):237–46. doi: 10.1179/1476830515Y.0000000010
   PubMed Web of Science ®Google Scholar
• Liu X, Wang T, Liu X, Cai L, Qi J, Zhang P, et al. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol. 2016;38:324–31. doi: 10.1016/j.intimp.2016.06.009
   PubMed Web of Science ®Google Scholar
• Chen H, Jin Z, Li G. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci Lett. 2007;417(2):112–17. doi: 10.1016/j.neulet.2006.11.045
   PubMed Web of Science ®Google Scholar
• Kaur D, Peng J, Chinta S J, Rajagopalan S, Di Monte D A, Cherny R A, et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28(6):907–13. doi: 10.1016/j.neurobiolaging.2006.04.003
   PubMed Web of Science ®Google Scholar
• Guan Q, Wang M, Chen H, Yang L, Yan Z, Wang X. Aging-related 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurochemial and behavioral deficits and redox dysfunction: improvement by AK-7. Exp Gerontol. 2016;82:19–29. doi: 10.1016/j.exger.2016.05.011
   PubMed Web of Science ®Google Scholar
• Yu L, Wang X, Chen H, Yan Z, Wang M, Li Y. Neurochemical and behavior deficits in rats with iron and rotenone co-treatment: role of redox imbalance and neuroprotection by biochanin A. Front Neurosci. 2017;11(657):1–11. doi:10.3389/fnins.2017.00657.
   PubMedGoogle Scholar
• Zhang Q, Heng Y, Mou Z, Huang J, Yuan Y, Chen N. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta Pharmacol Sin. 2017;38(10):1317–28. doi: 10.1038/aps.2017.49
   PubMed Web of Science ®Google Scholar
• Muralikrishnan D, Mohanakumar KP. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J. 1998;12(10):905–12. doi: 10.1096/fasebj.12.10.905
   PubMed Web of Science ®Google Scholar
• Chen H, Wang X, Wang M, Yang L, Yan Z, Zhang Y, et al. Behavioral and neurochemical deficits in aging rats with increased neonatal iron intake: Silibinin's neuroprotection by maintaining redox balance. Front Aging Neurosci. 2015;7(206):1–10. doi:10.3389/fnagi.2015.00206.
   PubMedGoogle Scholar
• Peskin A, Winterbourn C. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin Chim Acta. 2000;293(1-2):157–66. doi: 10.1016/S0009-8981(99)00246-6
   PubMed Web of Science ®Google Scholar
• Han J, Plummer J, Liu L, Byrd A, Aschner M, Erikson KM. The impact of obesity on brain iron levels and alpha-synuclein expression is regionally dependent. Nutr Neurosci. 2017;16:1–9.
   Google Scholar
• Tan J, Tham C, Israf D, Lee S, Kim M. Neuroprotective effects of biochanin A against glutamate-induced cytotoxicity in PC12 cells via apoptosis inhibition. Neurochem Res. 2013;38(3):512–18. doi: 10.1007/s11064-012-0943-6
   PubMed Web of Science ®Google Scholar
• Cheepsunthorn P, Radov L, Menzies S, Reid J, Connor J. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia. 2001;35(1):53–62. doi: 10.1002/glia.1070
   PubMed Web of Science ®Google Scholar
• Cheng J, Liao Y, Xiao L, Wu R, Zhao S, Chen H, et al. Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia. Cell Death Differ. 2017;24(2):276–87. doi: 10.1038/cdd.2016.121
   PubMed Web of Science ®Google Scholar
• Urrutia P, Hirsch E, González-Billault C, Núñez M. Hepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia. J Neurochem. 2017;142(1):140–52. doi: 10.1111/jnc.14005
   PubMed Web of Science ®Google Scholar
• Schneider N, Garcia-Rodenas CL. Early nutritional interventions for brain and cognitive development in preterm infants: a review of the literature. Nutrients. 2017;9(3):187. doi:10.3390/nu9030187.
   Web of Science ®Google Scholar
• Domellof M, Braegger C, Campoy C, Colomb V, Decsi T, Fewtrell M, et al. Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr. 2014;58(1):119–29. doi: 10.1097/MPG.0000000000000206
   PubMed Web of Science ®Google Scholar
• Connor J, Pavlick G, Karli D, Menzies S, Palmer C. A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol. 1995;355(1):111–23. doi: 10.1002/cne.903550112
   PubMed Web of Science ®Google Scholar
• Fredriksson A, Schroder N, Eriksson P, Izquierdo I, Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol. 1999;159(1):25–30. doi: 10.1006/taap.1999.8711
   PubMed Web of Science ®Google Scholar
• Gillies G, Pienaar I, Vohra S, Qamhawi Z. Sex differences in Parkinson's disease. Front Neuroendocrinol. 2014;35(3):370–84. doi: 10.1016/j.yfrne.2014.02.002
   PubMed Web of Science ®Google Scholar
• Bolam J, Pissadaki E. Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord. 2012;27(12):1478–83. doi: 10.1002/mds.25135
   PubMed Web of Science ®Google Scholar
• Zucca F, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Prog Neurobiol. 2017;155:96–119. doi: 10.1016/j.pneurobio.2015.09.012
   PubMed Web of Science ®Google Scholar
• Yolland COB, Phillipou A, Castle DJ, Neill E, Hughes ME, Galletly C, et al. Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutr Neurosci. 2018:1–10. doi:10.1080/1028415X.2018.1478766.
   PubMed Web of Science ®Google Scholar
• Macedo RC, Bondan EF, Otton R. Redox status on different regions of the central nervous system of obese and lean rats treated with green tea extract. Nutr Neurosci. 2017;22:119–31. doi: 10.1080/1028415X.2017.1356030
   PubMed Web of Science ®Google Scholar
• Kole L, Giri B, Manna S, Pal B, Ghosh S. Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation. Eur J Pharmacol 2011;653(1–3):8–15. doi: 10.1016/j.ejphar.2010.11.026
   PubMed Web of Science ®Google Scholar
• Sandini TM, Reis-Silva TM, Moreira N, Bernardi MM, Lebrun I, Spinosa HS. Effects of isoflavones on behavior, estradiol, glutamate, and GABA levels in intact middle-aged female rats. Nutr Neurosci. 2018:1–12. doi:10.1080/1028415X.2018.1447296.
   PubMed Web of Science ®Google Scholar
• Wang W, Tang L, Li Y, Wang Y. Biochanin A protects against focal cerebral ischemia/reperfusion in rats via inhibition of p38-mediated inflammatory responses. J Neurol Sci. 2015;348(1-2):121–5. doi: 10.1016/j.jns.2014.11.018
   PubMed Web of Science ®Google Scholar
• Khanna S, Stewart R, Gnyawali S, Harris H, Balch M, Spieldenner J, et al. Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke. FASEB J. 2017;31(10):4533–44. doi: 10.1096/fj.201700353
   PubMed Web of Science ®Google Scholar
• Fisher DR, Poulose SM, Bielinski DF, Shukitt-Hale B. Serum metabolites from walnut-fed aged rats attenuate stress-induced neurotoxicity in BV-2 microglial cells. Nutr Neurosci. 2017;20(2):103–9. doi: 10.1179/1476830514Y.0000000150
   PubMed Web of Science ®Google Scholar
• Rojo A, McBean G, Cindric M, Egea J, López M, Rada P, et al. Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal. 2014;21(12):1766–801. doi: 10.1089/ars.2013.5745
   PubMed Web of Science ®Google Scholar
• Dou F, Chu X, Zhang B, Liang L, Lu G, Ding J, et al. Erib targeted inhibition of microglia activity attenuates MPP+ induced DA neuron injury through the NF-kappaB signaling pathway. Mol Brain. 2018;11(1):75. doi: 10.1186/s13041-018-0418-z
   PubMedGoogle Scholar
• Chen T, Hou R, Xu S, Wu C. Donepezil regulates 1-methyl-4-phenylpyridinium-induced microglial polarization in Parkinson's disease. ACS Chem Neurosci. 2015;6(10):1708–14. doi: 10.1021/acschemneuro.5b00026
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Konerth M, Kokiko Cochran O, Cardona A, Ransohoff R, Lamb B. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68(1):19–31. doi: 10.1016/j.neuron.2010.08.023
   PubMed Web of Science ®Google Scholar
• Jalaludeen A M, Ha W T, Lee R, Kim J H, Do J T, Park C, et al. Biochanin A ameliorates arsenic-induced hepato- and hematotoxicity in rats. Molecules. 2016;21(1):69. doi: 10.3390/molecules21010069
   PubMed Web of Science ®Google Scholar
• Dowling S, Regan F, Hughes H. The characterisation of structural and antioxidant properties of isoflavone metal chelates. J Inorg Biochem. 2010;104(10):1091–8. doi: 10.1016/j.jinorgbio.2010.06.007
   PubMed Web of Science ®Google Scholar